Log in to save to my catalogue

Effect of mitotane in patients with ectopic adrenocorticotropic hormone syndrome caused by advanced...

Effect of mitotane in patients with ectopic adrenocorticotropic hormone syndrome caused by advanced...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f8e48ff13e434d2497c3cd2e088d6fec

Effect of mitotane in patients with ectopic adrenocorticotropic hormone syndrome caused by advanced pancreatic neuroendocrine tumors: a case series and review of the literature

About this item

Full title

Effect of mitotane in patients with ectopic adrenocorticotropic hormone syndrome caused by advanced pancreatic neuroendocrine tumors: a case series and review of the literature

Publisher

London, England: SAGE Publications

Journal title

Journal of international medical research, 2024-01, Vol.52 (1), p.3000605231220867-3000605231220867

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Ectopic adrenocorticotropic hormone syndrome (EAS) is a rare condition caused by pancreatic neuroendocrine tumors (p-NETs). The severe hypercortisolemia that characterizes EAS is associated with a poor prognosis and survival. Mitotane is the only adrenolytic drug approved by the Food and Drug Administration and is often used to treat adrenocortical...

Alternative Titles

Full title

Effect of mitotane in patients with ectopic adrenocorticotropic hormone syndrome caused by advanced pancreatic neuroendocrine tumors: a case series and review of the literature

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f8e48ff13e434d2497c3cd2e088d6fec

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f8e48ff13e434d2497c3cd2e088d6fec

Other Identifiers

ISSN

0300-0605

E-ISSN

1473-2300

DOI

10.1177/03000605231220867

How to access this item